In terms of the individual MACE components, the present study informs clinicians that the impact of GLP-1RA, based on the NNT, is predominantly in the reduction of coronary revascularization risk, followed by total MI, then cardiovascular mortality, non-fatal MI and stroke
Persistent cough was identified using repeated diagnostic codes, cough-related clinical encounters, or ENT visits over time rather than isolated acute episodes
Tissue sources for stem cell therapy include bone marrow (BM), UC/AF, urine, and adipose tissue
Its role in human physiology is multifaceted: Stimulates insulin secretion from pancreatic beta cells Suppresses glucagon release from alpha cells Slows gastric emptying, improving satiety Acts on the brain, reducing appetite and promoting satiety Unlike insulin, which has been a focus of metabolic treatment for over a century, GLP-1s therapeutic potential was not fully appreciated until the late 20th century